Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma

被引:7
|
作者
Shen, Xuqing [1 ]
Niu, Ningning [1 ]
Xue, Jing [1 ]
机构
[1] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Stem Cell Res Ctr, Ren Ji Hosp,Sch Med,Shanghai Canc Inst, Shanghai 200127, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic ductal adenocarcinoma; oncogenic KRAS activation; metabolic reprogramming; POSITRON-EMISSION-TOMOGRAPHY; FATTY-ACID-METABOLISM; GLUTAMINE-METABOLISM; TUMOR-GROWTH; GEMCITABINE RESISTANCE; CANCER GROWTH; CELL-GROWTH; K-RAS; GLUCOSE; INHIBITOR;
D O I
10.2478/jtim-2022-0022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with an extremely high lethality rate. Oncogenic KRAS activation has been proven to be a key driver of PDAC initiation and progression. There is increasing evidence that PDAC cells undergo extensive metabolic reprogramming to adapt to their extreme energy and biomass demands. Cell-intrinsic factors, such as KRAS mutations, are able to trigger metabolic rewriting. Here, we update recent advances in KRAS-driven metabolic reprogramming and the associated metabolic therapeutic potential in PDAC.
引用
收藏
页码:322 / 329
页数:8
相关论文
共 50 条
  • [21] Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma
    Zhao, Tiansuo
    Jiang, Tingting
    Li, Xiaojia
    Chang, Shaofei
    Sun, Qihui
    Kong, Fanyang
    Kong, Xiangyu
    Wei, Fang
    He, Jie
    Hao, Jihui
    Xie, Keping
    CLINICAL CANCER RESEARCH, 2023, 29 (24) : 5183 - 5195
  • [22] Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
    Dey, Prasenjit
    Li, Jun
    Zhang, Jianhua
    Chaurasiya, Surendra
    Strom, Anders
    Wang, Huamin
    Liao, Wen-Ting
    Cavallaro, Frederick
    Denz, Parker
    Bernard, Vincent
    Yen, Er-Yen
    Genovese, Giannicola
    Gulhati, Pat
    Liu, Jielin
    Chakravarti, Deepavali
    Deng, Pingna
    Zhang, Tingxin
    Carbone, Federica
    Chang, Qing
    Ying, Haoqiang
    Shang, Xiaoying
    Spring, Denise J.
    Ghosh, Bidyut
    Putluri, Nagireddy
    Maitra, Anirban
    Wang, Y. Alan
    DePinho, Ronald A.
    CANCER DISCOVERY, 2020, 10 (04) : 608 - 625
  • [23] KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
    Zhang, Zining
    Zhang, Heng
    Liao, Xiang
    Tsai, Hsiang-i
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [24] Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
    Liu, Yu-Huei
    Hu, Chun-Mei
    Hsu, Yuan-Sheng
    Lee, Wen-Hwa
    CELL DEATH & DISEASE, 2022, 13 (09)
  • [25] Concentrations of trace elements and KRAS mutations in pancreatic ductal adenocarcinoma
    Gomez-Tomas, Alvaro
    Pumarega, Jose
    Alguacil, Juan
    Amaral, Andre F. S.
    Malats, Nuria
    Pallares, Natalia
    Gasull, Magda
    Porta, Miquel
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2019, 60 (08) : 693 - 703
  • [26] Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
    Yu-Huei Liu
    Chun-Mei Hu
    Yuan-Sheng Hsu
    Wen-Hwa Lee
    Cell Death & Disease, 13
  • [27] KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
    Yu Shuang-Ni
    Ma Yi-Hui
    Zhao Wu-Gan
    Jin Xiang-Lan
    Yang Hai-Yan
    Liu Ping-Ping
    Chen Jie
    慢性疾病与转化医学(英文), 2016, 2 (04)
  • [28] Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
    de Jesus, Victor Hugo Fonseca
    Mathias-Machado, Maria Cecilia
    de Farias, Joao Paulo Fogacci
    Aruquipa, Marcelo Porfirio Sunagua
    Jacome, Alexandre A.
    Peixoto, Renata D'Alpino
    CANCERS, 2023, 15 (20)
  • [29] KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
    Mahmoud Yousef
    Abdelrahman Yousef
    Mark W. Hurd
    Ashwathy Pillai
    Saikat Chowdhury
    Rebecca Snyder
    Mark Knafl
    Ryan L. Lewis
    Paul M. Roy
    Mohammad Fanaeian
    Sali Albarouki
    Luca F. Castelnovo
    Jennifer Peterson
    Brandon G. Smaglo
    Robert A. Wolff
    Shubham Pant
    Jason Willis
    Ryan Huey
    Michael Overman
    Ching-Wei Tzeng
    Michael P. Kim
    Naruhiko Ikoma
    Jess E. Maxwell
    Matthew H. G. Katz
    Huamin Wang
    Anirban Maitra
    Eugene Koay
    Ethan B. Ludmir
    Anthony Chen
    Camila Lopez
    Haoqiang Ying
    John Paul Shen
    Dan Zhao
    Journal of Hematology & Oncology, 18 (1)
  • [30] Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
    Liang, Chen
    Qin, Yi
    Zhang, Bo
    Ji, Shunrong
    Shi, Si
    Xu, Wenyan
    Liu, Jiang
    Xiang, Jinfeng
    Liang, Dingkong
    Hu, Qiangsheng
    Ni, Quanxing
    Xu, Jin
    Yu, Xianjun
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2016, 1866 (02): : 177 - 188